Breaking News

One2Treat Raises Capital with Seed Extension

Aims to further accelerate software platform development.

Author Image

By: Charlie Sternberg

Associate Editor

One2Treat SA, a technology company transforming how the patient voice is integrated into clinical development, has completed a planned seed extension to accelerate its software platform development. The conclusion of One2Treat’s planned seed extension funding round marks a milestone in the company’s growth. This investment follows the successful deployment of the One2Treat Insights module across multiple live projects and the recent release of the One2Treat Voice module. It reflects the confi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters